The effects of local microinjection of ArgS-vasopressin, cyclo[Lys-Gly] and L-PrO-L-Leu-GIyNH 2 (PLG) were studied on the a-MPT-induced disappearance of dopamine and noradrenaline in the amygdala and in a number of other brain regions. A dose-dependent increase in dopamine utilization was found in the amygdala after local microinjection of ArgS-vasopressin, cyclo[Lys-Gly] and PLG at doses of 0.1, 2.7 and 18 pmol respectively. No effects were found on noradrenaline utilization in this brain region. Using a microdissection method, it was found that cyclo[Lys-Gly] enhanced dopamine utilization in the nucl. amygdaloideus centralis, whereas the effect of PLG was mainly located in the nucl. amygdaloideus corticalis. These effects of ArgS-vasopressin, cyclo [Lys-Gly] and PLG on dopamine utilization in the amygdala are correlated with those on avoidance behavior and can be interpreted as in support of the role of dopamine as neurotransmitter involved in retrieval processes.
In the mammalian brain extensive neuronal networks containing vasopressin and oxytocin have been found to occur, with intra-and extrahypothalamic cell body regions with fibers projecting to the pituitary and various limbic-midbrain and hindbrain regions4. Vasopressin and oxytocin are secreted from the pituitary into the bloodstream and act as hormones for peripheral target organs. In the brain vasopressin and oxytocin act as neuropeptides involved in the control of a variety of physiological functions such as brain development, neuroendocrine and cardiovascular regulations, maternal behavior, memory processes, self-stimulation behavior, as well as the development of tolerance and addiction to narcotic drugs (for literature see ref. 16). Whereas for the peripheral action of the hormones the whole molecule appears to be necessary, CNS processes can also be influenced by fragments and derivatives of the molecule 9,11,16. In particular the structural requirements for the effects on memory processes are well documented11.
Lesion and microinjection studies have indicated that regions rich in terminals of both neurohypophyseal hormone-containing neurons and catecholamine neurons are the site of action for the effects of vasopressin and oxytocin on memory processes9,10, 20. Vasopressin and oxytocin and fragments of these neuropeptides affect the activity of distinct catecholaminecontaining systems in the brain20. A strong correlation was found between the facilitating effect of vasopressin on memory consolidation and its enhancing effect on the utilization of noradrenaline in distinct terminal regions of the coeruleo-telencephalic noradrenaline system9, to. It seems likely that not only consolidation but also the retrieval of stored information might be correlated with alterations in the activity of particular catecholamine-containing neurons.
Lesion studies have shown that the amygdala is one of the brain sites involved in memory processes 19. Results of studies in which vasopressin and related peptides were microinjected into the amygdala showed that these peptides could antagonize disturbed retrieval processes3, while they did not influence the consolidation process 10. In the present study we investigated the effect of microinjection of ArgSvasopressin, cyclo[Lys-Gly] and L-Pro-L-Leu-GlyNH2 into the amygdala on the a-MPT-induced disappearance of dopamine and noradrenaline in a number of 
